首页 | 本学科首页   官方微博 | 高级检索  
     

原发纵隔淋巴瘤研究进展:第19届欧洲血液学会年会报道
引用本文:庞一帆,王晶,克晓燕. 原发纵隔淋巴瘤研究进展:第19届欧洲血液学会年会报道[J]. 白血病.淋巴瘤, 2014, 23(10): 589-592
作者姓名:庞一帆  王晶  克晓燕
作者单位:100191,北京大学第三医院血液科
摘    要:原发纵隔大B细胞淋巴瘤(PMBCL)是一种特殊类型的B细胞淋巴瘤,推测来源于胸腺髓质B细胞,占所有弥漫大B细胞淋巴瘤(DLBCL)的6%~10%,具有特殊的病理特征、免疫表型和基因异常,需要与经典型霍奇金淋巴瘤和其他结性DLBCL亚型鉴别.文章就PMBCL的病理学特征、分子生物学改变、治疗、预后及正电子发射型计算机断层扫描显像(PET)在评估初始治疗反应中的作用进行介绍.

关 键 词:原发纵隔大B细胞淋巴瘤  治疗  预后  欧洲血液学会年会

Primary mediastinal lymphoma: reports from the 19th European Hematology Association annual congress
Pang Yifan,Wang Jing,Ke Xiaoyan. Primary mediastinal lymphoma: reports from the 19th European Hematology Association annual congress[J]. Journal of Leukemia & Lymphoma, 2014, 23(10): 589-592
Authors:Pang Yifan  Wang Jing  Ke Xiaoyan
Affiliation:( Department of Hematology, Peking University Third Hospital, Bering 100191, China)
Abstract:Primary mediastinal large B-cell lymphoma (PMBCL) is a unique type of B-cell lymphoma probably arising from a putative thymic medulla B cell.It constitutes 6 %-10 % of all diffuse large B-cell lymphomas (DLBCL),with special pathologic features,immunophenotype and genetic abnormlities,and need to be identified with classical Hodgkin lymphoma and other types of DLBCL.In this review,the pathological features,molecular biological changes,treatment,prognosis and treatment of PET in the evaluation of the initial reaction in PMBCL were summarized.
Keywords:Primary mediastinal large B-cell lymphoma  Treatment  Prognosis  19th Congress of the European Hematology Association
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号